Loading...
Loading...
Among the 5 tracked institutional investors we monitor, GANX (GAIN THERAPEUTICS INC) is held with a combined value of $4.64M across 1,611,694 shares. The largest holder is GREENLIGHT CAPITAL INC with a position worth $1.92M (0.09% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 1 fund increased its holdings. 1 fund reduced its position.
Total Institutional Value
$4.64M
Total Shares Held
1,611,694
Institutional Holders
5
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | GREENLIGHT CAPITAL INC | $1.92M | 0.09% | - |
| 2 | VANGUARD GROUP INC | $1.84M | 0.00% | New |
| 3 | BlackRock, Inc. | $436.59K | 0.00% | +7.4% |
| 4 | STATE STREET CORP | $305.62K | 0.00% | - |
| 5 | CITADEL ADVISORS LLC | $137.35K | 0.00% | -8.6% |
As of the latest SEC 13F filings, GREENLIGHT CAPITAL INC is the largest institutional holder of GANX with a position worth $1.92M, representing 0.09% of their portfolio. In total, 5 institutional investors hold GANX with a combined value of $4.64M.
In the most recent quarter, 1 fund opened a new position in GANX. Additionally, 1 increased their holdings and 1 reduced their positions.
Institutional investors hold $4.64M worth of GANX stock across 5 positions. The largest institutional holder is GREENLIGHT CAPITAL INC with $1.92M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For GANX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their GANX positions.